Michael Boettger

Michael Boettger

Company: Bayer

Job title: Vice President, Head Experimental Medicine CV


Panel Discussion: How Can We Invigorate AKI Drug Development? Identifying Novel Targets & Establishing a Pathway to Surmount Challenges in Biomarkers & Precision Medicine 2:15 pm

What can we learn from clinical setbacks in AKI? Addressing translational barriers in AKI: optimizing models to predict efficacy and biomarkers of therapeutic target engagement Characterizing endophenotypes through omics approaches to enable comprehensive, longitudinal understanding of AKIRead more

day: Seminar Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.